Liquid Biopsy by ctDNA in Liver Transplantation for Colorectal Cancer Liver Metastasis

Chase J. Wehrle,Roma Raj,Nihal Aykun,Danny Orabi,Bassam Estfan,Suneel Kamath,Smitha Krishnamurthi,Masato Fujiki,Koji Hashimoto,Cristiano Quintini,David Choon Hyuck Kwon,Teresa Diago-Uso,Kazunari Sasaki,Federico N. Aucejo
DOI: https://doi.org/10.1007/s11605-023-05723-8
2023-06-06
Journal of Gastrointestinal Surgery
Abstract:Colorectal cancer is a leading cause of cancer-related death worldwide. Metastatic liver disease develops in 50% of cases and drives patient outcomes. Although the ideal treatment for colorectal cancer liver metastases (CRLM) is resection, only a third of patients are suitable for this approach. Reports of liver transplantation in selected patients with unresectable CRLM have shown encouraging results compared to conventional forms of therapy. No study to date has examined the utility of liquid biopsy circulating tumor DNA (ctDNA) for evaluation of residual disease in this cohort of patients. We report a small series of liver transplantation in patients with CRLM in whom ctDNA was assessed peri-operatively.
gastroenterology & hepatology,surgery
What problem does this paper attempt to address?